Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Vor Biopharma Inc. Director's Dealing 2021

Feb 5, 2021

33479_dirs_2021-02-04_d5842a80-ec7d-4659-8bed-0819b24e1a5b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Vor Biopharma Inc. (VOR)
CIK: 0001817229
Period of Report: 2021-02-04

Reporting Person: Resnick Joshua (Director)

More from Vor Biopharma Inc.

Interim / Quarterly Report 2026
May 13
Annual Report 2026
Apr 27
Proxy Solicitation & Information Statement 2026
Apr 27
Capital/Financing Update 2026
Mar 30
Annual Report 2026
Mar 30
Capital/Financing Update 2026
Mar 27
Major Shareholding Notification 2026
Feb 17
Major Shareholding Notification 2026
Feb 17
Major Shareholding Notification 2026
Feb 17
Major Shareholding Notification 2026
Feb 17
View all filings →